Bacterial News and Research

RSS

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.

21 Oct 2004

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Sinusitis and bronchitis take a significant toll on a person's ability to participate in everyday life and have a sizable economic impact, accounting for more than 30 million missed workdays each year

21 Oct 2004

Common antibacterial and antifungal ingredient used in tooth paste may protect against skin cancer

According to new studies, sanguinarine was shown to enhance production of proteins that induce cell death, or apoptosis, in cells damaged by ultraviolet-B (UVB) radiation.

21 Oct 2004

Babies born by Caesarean section may be at greater risk of diarrhoea

Babies born by Caesarean section may be at greater risk of diarrhoea and sensitisation to certain foodstuffs during their first 12 months than babies born vaginally, suggests research in the Archives of Disease in Childhood.

21 Oct 2004

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Patients with chronic rhinosinusitis (CRS, inflammation of the nasal passages and sinuses) do not necessarily develop resistance to antibiotics although they may be treated for long periods of time with these drugs

18 Oct 2004

The prevalence of Helicobacter pylori is high among patients about to undergo weight loss surgery

The prevalence of Helicobacter pylori (a type of bacteria associated with gastrointestinal disorders) is high among patients about to undergo weight loss surgery, and treatment to eradicate the bacterial infection before surgery may be beneficial, according to an article in the October issue of The Archives of Surgery.

18 Oct 2004

Benitec receives exclusive rights to use DNA technology pioneered at Stanford University for all RNAi therapeutic uses

Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.

18 Oct 2004

Discovery of compound that renders the MRSA superbug vulnerable to antibiotics

MRSA- methicillin-resistant Staphylococcus aureus- is defined by its ability to resist the antibiotic methicillin. Like penicillin, methicillin works by blocking bacterial enzymes called PBPs, which normally strengthen cell walls by forming cross links.

13 Oct 2004

Global effort to relieve chronic pain

The World Health Organization (WHO) co-sponsors the first Global Day Against Pain, which seeks to draw global attention to the urgent need for better pain relief for sufferers from diseases such as cancer and AIDS.

11 Oct 2004

Combination of computer science and biology could aid cancer research

The technique helps to show how cells modify their own genetic makeup and may allow cancer treatments to be tailored more precisely to a patient's disease.

11 Oct 2004

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.

11 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

New targets for combating infections in medical implants

Navarre researcher, Jaione Valle Turrillas, has identified two genes that could help as targets for pharmaceutical drugs that fight the Staphylococcus aureus bacteria - one of the bacteria which causes most infections in medical implants.

8 Oct 2004

Research shows C. botulinum uses SONO to detect nitric oxide

A deadly bacterium's defense against a mortal molecular enemy illuminates the origins and structure of a vital protein involved in human cell signaling, University of Texas Medical School scientists report in Science Express.

8 Oct 2004

Britain's Chief Medical Officer has announced new measures to tackle and eliminate tuberculosis in Britain

The Plan, Stopping Tuberculosis in England, provides a strong commitment to tackle the disease by increasing the awareness of the disease amongst health professional and the public, establishing high quality surveillance to monitor the disease concentrating on high risk groups, identifying the infection early, and ensuring excellence in clinical care for patients with TB.

7 Oct 2004

Researchers identify new sulfur-containing scent molecules in sweat

Sometimes, people just don't smell good – and not only in the figurative sense. The sense of smell plays an important role in interpersonal relations.

7 Oct 2004

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Influenza (or as it is commonly known, the flu) is a contagious disease caused by an RNA virus of the orthomyxoviridae family (The orthomyxoviridae is a family of RNA viruses which infect vertebrate).

6 Oct 2004

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

New biotechnology company, RiboNovix, Inc., is addressing the worsening problem of antibiotic-resistant bacteria by developing new anti-infectives that are less susceptible to drug resistance.

5 Oct 2004

Virginia Department of Health and the Get Smart Virginia program are urging consumers to become educated this cold and flu

Additionally, Governor Mark Warner has declared October 2004 Antibiotic Awareness Month in an effort to increase the public’s knowledge about the growing problem of resistance to antibiotic medications.

5 Oct 2004

Researchers to develop dietary agents to reduce risk of cataracts for astronauts

Astronauts are at increased risk of cataracts because of space radiation. In fact, it is estimated during a long space flight to Mars and back, about one quarter of the crew would become blind because of space radiation-induced cataracts. Other groups which are at increased risk are jet crews, radiation workers and radiation accident cleanup workers.

5 Oct 2004

Bacterial News and Research

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Common antibacterial and antifungal ingredient used in tooth paste may protect against skin cancer

Babies born by Caesarean section may be at greater risk of diarrhoea

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

The prevalence of Helicobacter pylori is high among patients about to undergo weight loss surgery

Benitec receives exclusive rights to use DNA technology pioneered at Stanford University for all RNAi therapeutic uses

Discovery of compound that renders the MRSA superbug vulnerable to antibiotics

Global effort to relieve chronic pain

Combination of computer science and biology could aid cancer research

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

New targets for combating infections in medical implants

Research shows C. botulinum uses SONO to detect nitric oxide

Britain's Chief Medical Officer has announced new measures to tackle and eliminate tuberculosis in Britain

Researchers identify new sulfur-containing scent molecules in sweat

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

Virginia Department of Health and the Get Smart Virginia program are urging consumers to become educated this cold and flu

Researchers to develop dietary agents to reduce risk of cataracts for astronauts

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News